EBITDA Margin ratio Analysis of Kazia Therapeutics Ltd ADR - Deep Dive
Latest FY EBITDA Margin
Period Ending - Jun-23
Very Poor EBITDA Margin
-4350825.59
Period Ending - Jun-22
Very Poor EBITDA Margin
-100055204.00
Growth
95.65 %
Trailing Twelve Months EBITDA Margin
Period Ending - Jun-23
Very Poor EBITDA Margin
-3123711.59
Most recent Quarter EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-158973960.00
EBITDA Margin Analysis of Kazia Therapeutics Ltd ADR
Ebitda Margin Ratio of Kazia Therapeutics Ltd ADR with value of -3123711.59 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
Ebitda Margin Ratio of Kazia Therapeutics Ltd ADR with value of -158973960.00 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Dec-23. |
EBITDA Margin Ratio of KZIA rose handsomely by 95.65 % this year. |
EBITDA Margin Ratio with value of -16.75 was highest in Year Jun-21 in last Five Years. |
EBITDA Margin Ratio with value of -100055204.00 was lowest in Year Jun-22 in last Five Years. |
Latest EBITDA Margin Ratio with value of -4350825.59 is Greater than Average EBITDA Margin of -21222599.05 in last five years. |
Ebitda Margin of Kazia Therapeutics Ltd ADR is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months |
Other EBITDA Margin Related Info of KZIA that may interest you.
Kazia Therapeutics Ltd ADR Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
KZIA | 0.26 | 0.2497 | 4.12 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..EBITDA Margin Related Ratios
NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical EBITDA Margin of Kazia Therapeutics Ltd ADR
Period | Jun-23 | Jun-22 | Jun-21 | Jun-20 | Jun-19 | Jun-18 | Jun-17 |
---|---|---|---|---|---|---|---|
EBITDA Margin | -4350825.59 | -100055204.00 | -16.75 | -1100942.51 | -606006.39 | -36595.97 | -98.81 |
Change | 95.65 % | -597380223.37 % | 100.00 % | -81.67 % | -1555.94 % | -36935.25 % | 96.49 % |
FY Chart of EBITDA Margin of Kazia Therapeutics Ltd ADR
Note : All Data Generated at the End of Trading Hours (EOD Data)